Biggest News Aggregation in the World
📰 Multiple Sclerosis News

Page 57 - Multiple Sclerosis News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Multiple Sclerosis. Real-time updates on events, politics, business and more.

PolTREG CEO Trzonkowski co-authors peer-reviewed article showing scientific progress in T-reg autoimmune therapy

30.01.2024 -                Gdańsk, Poland – 30 January 2024 – PolTREG S.A. (Warsaw Stock Exchange: PTG) , a clinical-stage biotechnology company developing cell therapies for a wide range of autoimmune diseases, announced that Prof. Piotr Trzonkowski, CEO, ... Seite 1
Anke Fuchs Natalia Marek Trzonkowska Piotr Trzonkowski Technical University Of Dresden Poltreg Sa Warsaw Stock Exchange University Of Gda

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

FibroBiologics Inc. (FBLG) Plans to Raise $0 in January 31st IPO

FibroBiologics Inc. (FBLG) plans to raise $0 in an initial public offering on Wednesday, January 31st, IPO Scoop reports. The company will issue 4,806,226 shares at a price of $0.00 per share. FibroBiologics (Direct Listing) provided the following description of their company for its IPO: “Note: This is NOT an IPO. This is a NASDAQ […]
United States Drug Administration Fibrobiologics Inc Maxim Group News Ratings For Fibrobiologics Inc Direct Listing

Psyched: Suggestibility And Psychedelics' Effects, EU's $7M Research Fund, Australia's Treatment Delivery, BZ Podcast And More - ATAI Life Sciences (NASDAQ:ATAI), Clearmind Medicine (NASDAQ:CMND)

New study finds suggestibility plays a role in antidepressant effects of psilocybin therapy. EU invests 6.5M euros in psychedelics for pulmonary disorder, MS, ALS, and Parkinson's. Australian psychiatrists provide first psychedelic-assisted treatments in 50 years.
Clearmind Medicine Brandon Weiss David Nutt Incannex Healthcare Ted Cassidy Joel Latham

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science